Santen, a company with over 130 years of history, stands as a specialized leader in the field of ophthalmology. Dedicated to improving the well-being of patients worldwide, Santen focuses on the research, development, marketing, and sales of pharmaceuticals, over-the-counter products, and medical devices.
As the market leader for prescription ophthalmic pharmaceuticals in Japan, the company has successfully expanded its reach, with its products now available in more than 60 countries and regions. Santen's extensive scientific knowledge and robust organizational capabilities enable it to deliver high-quality products and services.
Despite the absence of specific data on its latest investments or founding year, Santen's established presence and leadership in the ophthalmic sector suggest a stable foundation for potential investors. The company's commitment to societal well-being through its contributions in eye care positions it as a compelling opportunity for stakeholders in the healthcare and pharmaceutical industries.